New consortium to monitor safety and effectiveness of COVID-19 vaccines
A new consortium to monitor the safety and effectiveness of COVID-19 vaccines has been formed, including the University of Dundee.
Archaeology uncovers infectious disease spread – 4000 years ago
New bioarchaeology research from a University of Otago PhD candidate has shown how infectious diseases may have spread 4000 years ago
A year on: Don’t let COVID-19 bring out the petty in us
On the anniversary of New Zealand's alert level 4 lockdown, Adjunct Professor Nicholas Agar argues COVID-19 in this country needs a branding refresh – and a return to the generosity of level 4.
Viruses can ‘hijack’ cellular process to block immune response
Research led by McGill University and Queen’s University Belfast has found that viruses can ‘hijack’ an existing molecular process in the cell in order to block the body’s antiviral immune response to a viral infection.
Majority of Dutch people not lining up for COVID-19 vaccine
An effective and safe COVID-19 vaccine is on the horizon. Still, a majority of people in the Netherlands say they’d rather not take a vaccine as soon as it becomes available, but wait instead.
Advisory report outlines opportunities for Amsterdam metropolitan region after the COVID crisis
The COVID-crisis has affected Amsterdam and the metropolitan area disproportionally: substantial unemployment, 5-10 months of backlog in children’s education...
Hopkins Engineers Develop Rapid COVID-19 Testing Platform
As new cases of COVID-19 surge across the country, states have ramped up their testing efforts, but increased testing and overburdened laboratories often means patients have to wait a week or more to find out if they're positive.
Students have a whale of a time
In March this year tourism companies ground to a halt as New Zealand went into lockdown in the wake of Covid-19.
Brazil cases shed more light on COVID-19 reinfection risk
Researchers believe reinfection with SARS-CoV-2 may be more common than previously thought, after an analysis of people contracting COVID-19 twice.
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly...
A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective...
